PL446009A1 - Sposób wykrywania materiału genetycznego wirusa SARS-CoV-2, sposób diagnozowania in vitro zakażenia wirusem SARS-CoV-2 w wersji POC i zestaw testowy - Google Patents

Sposób wykrywania materiału genetycznego wirusa SARS-CoV-2, sposób diagnozowania in vitro zakażenia wirusem SARS-CoV-2 w wersji POC i zestaw testowy

Info

Publication number
PL446009A1
PL446009A1 PL446009A PL44600923A PL446009A1 PL 446009 A1 PL446009 A1 PL 446009A1 PL 446009 A PL446009 A PL 446009A PL 44600923 A PL44600923 A PL 44600923A PL 446009 A1 PL446009 A1 PL 446009A1
Authority
PL
Poland
Prior art keywords
cov
sars
virus
genetic material
test kit
Prior art date
Application number
PL446009A
Other languages
English (en)
Other versions
PL249159B1 (pl
Inventor
Radosław CHARKIEWICZ
Piotr Majewski
Joanna Reszeć-Giełażyn
Janusz Bogdan Dzięcioł
Jacek NIKLIŃSKI
Joanna KIŚLUK
Anetta SULEWSKA
Piotr Karabowicz
Original Assignee
Akademicki Ośrodek Diagnostyki Patomorfologicznej I Genetyczno-Molekularnej Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akademicki Ośrodek Diagnostyki Patomorfologicznej I Genetyczno-Molekularnej Spółka Z Ograniczoną Odpowiedzialnością filed Critical Akademicki Ośrodek Diagnostyki Patomorfologicznej I Genetyczno-Molekularnej Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL446009A priority Critical patent/PL249159B1/pl
Publication of PL446009A1 publication Critical patent/PL446009A1/pl
Publication of PL249159B1 publication Critical patent/PL249159B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00—Reactions of nucleic acids characterised by
    • C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Niniejsze zgłoszenie dotyczy sposobu wykrywania w warunkach nie-laboratoryjnych materiału genetycznego wirusa SARS-CoV-2 w próbce materiału biologicznego, sposobu diagnozowania in vitro zakażenia wirusem SARS-CoV-2 z wykorzystaniem takiego sposobu wykrywania materiału genetycznego wirusa SARS-CoV-2 oraz zestawu do wykrywania materiału genetycznego wirusa SARS-CoV-2 lub diagnozowania zakażenia wirusem SARS-CoV-2 w próbce materiału biologicznego w warunkach nie-laboratoryjnych.
PL446009A 2023-09-01 2023-09-01 Sposób wykrywania materiału genetycznego wirusa SARS-CoV-2 oraz sposób diagnozowania in vitro zakażenia wirusem SARS-CoV-2 w wersji POC PL249159B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL446009A PL249159B1 (pl) 2023-09-01 2023-09-01 Sposób wykrywania materiału genetycznego wirusa SARS-CoV-2 oraz sposób diagnozowania in vitro zakażenia wirusem SARS-CoV-2 w wersji POC

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL446009A PL249159B1 (pl) 2023-09-01 2023-09-01 Sposób wykrywania materiału genetycznego wirusa SARS-CoV-2 oraz sposób diagnozowania in vitro zakażenia wirusem SARS-CoV-2 w wersji POC

Publications (2)

Publication Number Publication Date
PL446009A1 true PL446009A1 (pl) 2025-03-03
PL249159B1 PL249159B1 (pl) 2026-03-02

Family

ID=94771161

Family Applications (1)

Application Number Title Priority Date Filing Date
PL446009A PL249159B1 (pl) 2023-09-01 2023-09-01 Sposób wykrywania materiału genetycznego wirusa SARS-CoV-2 oraz sposób diagnozowania in vitro zakażenia wirusem SARS-CoV-2 w wersji POC

Country Status (1)

Country Link
PL (1) PL249159B1 (pl)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112760420A (zh) * 2021-02-05 2021-05-07 中国科学院长春应用化学研究所 一种用于检测新冠病毒SARS-CoV-2的引物、探针和试剂盒
CN113186357A (zh) * 2021-06-02 2021-07-30 上海真测生物科技有限公司 一种新型冠状病毒多重检测的rt-lamp引物组合及其试剂盒
WO2021245708A1 (en) * 2020-06-05 2021-12-09 Indian Council Of Medical Research A rapid and sensitive method for detecting sars-cov-2

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021245708A1 (en) * 2020-06-05 2021-12-09 Indian Council Of Medical Research A rapid and sensitive method for detecting sars-cov-2
CN112760420A (zh) * 2021-02-05 2021-05-07 中国科学院长春应用化学研究所 一种用于检测新冠病毒SARS-CoV-2的引物、探针和试剂盒
CN113186357A (zh) * 2021-06-02 2021-07-30 上海真测生物科技有限公司 一种新型冠状病毒多重检测的rt-lamp引物组合及其试剂盒

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HUANG X ET AL.: "EBioMedicine. 2022; 75: 103736", DEVELOPING RT-LAMP ASSAYS FOR RAPID DIAGNOSIS OF SARS-COV-2 IN SALIVA. *
LALLI MA ET AL.: "Clin Chem. 2021; 67(2): 415-424", RAPID AND EXTRACTION-FREE DETECTION OF SARS-COV-2 FROM SALIVA BY COLORIMETRIC REVERSE-TRANSCRIPTION LOOP-MEDIATED ISOTHERMAL AMPLIFICATION. *

Also Published As

Publication number Publication date
PL249159B1 (pl) 2026-03-02

Similar Documents

Publication Publication Date Title
Kaneko et al. Temporal changes in T cell subsets and expansion of cytotoxic CD4+ T cells in the lungs in severe COVID-19
Lee et al. Enzyme-linked immunospot assay for interferon-gamma in the diagnosis of tuberculous pleurisy
PH12020551371A1 (en) Assays to detect neurodegeneration
DE60227678D1 (de) Analyse zirkulierender tumorzellen, fragmente und trümmer
BRPI0707645B8 (pt) métodos in vitro para detecção de câncer em um indivíduo e para avaliação de prognóstico de um indivíduo tendo, ou suspeito de ter, câncer ovariano
BRPI1007867B8 (pt) anticorpo recombinante ou fragmento de ligação ao antígeno do mesmo, composição farmacêutica e kit compreendendo o referido anticorpo, métodos de detecção de antígeno de troponina i em uma amostra de teste e métodos in vitro de diagnóstico de síndrome coronariana aguda ou infarto do miocárdio em um paciente
RU2014117161A (ru) Композиции и способы испытаний на токсикогенность
EP3907509A3 (en) Diagnosis of early stage pancreatic cancer
Ngamsom et al. Rapid detection of Group B Streptococcus (GBS) from artificial urine samples based on IFAST and ATP bioluminescence assay: from development to practical challenges during protocol testing in Kenya
JP1747082S (ja) 検査器具
Alvarez et al. The efficacy of ELISA commercial kits for the screening of equine infectious anemia virus infection
AR071034A1 (es) Uso de la catepsina c en el diagnostico de susceptibilidad al dolor y para el tratamiento del dolor
MX2021009094A (es) Metodos y sistemas para la deteccion rapida de listeria utilizando agentes infecciosos.
PE20181498A1 (es) Anticuerpos monoclonales especificos para el antigeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por adv
Chen et al. A dual-aptamer sandwich assay by detection of C-reactive protein in synovial fluid on an integrated microfluidic system for diagnosis of periprosthetic joint infection
PL446009A1 (pl) Sposób wykrywania materiału genetycznego wirusa SARS-CoV-2, sposób diagnozowania in vitro zakażenia wirusem SARS-CoV-2 w wersji POC i zestaw testowy
Sibbitts et al. Measuring stimulation and inhibition of intracellular nitric oxide production in SIM-A9 microglia using microfluidic single-cell analysis
MX2022000882A (es) Componente de deteccion de antigenos de grupo sanguineo.
JP1747078S (ja) 検査器具
PL446010A1 (pl) Sposób wykrywania materiału genetycznego wirusa SARS-CoV-2, sposób diagnozowania in vitro zakażenia wirusem SARS-CoV-2 w wersji laboratoryjnej i zestaw testowy
BR112018008928A2 (pt) um método ex vivo para testar a capacidade de resposta celular de populações de células primárias a um fármaco ou combinação de fármacos
AR105439A1 (es) Procedimientos de purificación de un virus producido in vitro y ensayo de eliminación del virus
MX2016010144A (es) Gangliosidos para estandarizacion y aumento de la sensibilidad de las celulas a las neurotoxinas botulinicas en sistemas de prueba in vitro.
FR2973109B1 (fr) Methode cytologique utilisant l'autofluorescence des globules blancs pour le diagnostic precoce et le suivi des infections
BR112023019894A2 (pt) Composições e métodos para avaliar os danos ao dna em uma biblioteca e normalizar a distorção do tamanho do amplicon